Recent research has suggested that MDG-1 could reduce hyperglycemia, hyperinsulinemia and hyperlipidemia in the spontaneous model of type 2 diabetes in ob/ob mice or KKAy mice [14,15,16]. The gene discussed is DNAJB9; the disease is hyperlipidemia.